- Home
- INM vs OZKAP Comparison
INM vs OZKAP Comparison
Compare INM & OZKAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- OZKAP
- Stock Information
- Founded
- INM 1981
- OZKAP N/A
- Country
- INM Canada
- OZKAP United States
- Employees
- INM N/A
- OZKAP 3205
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- OZKAP Major Banks
- Sector
- INM Health Care
- OZKAP Finance
- Exchange
- INM Nasdaq
- OZKAP Nasdaq
- Market Cap
- INM 5.0M
- OZKAP N/A
- IPO Year
- INM N/A
- OZKAP N/A
- Fundamental
- Price
- INM $1.85
- OZKAP $17.25
- Analyst Decision
- INM
- OZKAP
- Analyst Count
- INM 0
- OZKAP 0
- Target Price
- INM N/A
- OZKAP N/A
- AVG Volume (30 Days)
- INM 105.5K
- OZKAP N/A
- Earning Date
- INM 11-13-2025
- OZKAP N/A
- Dividend Yield
- INM N/A
- OZKAP N/A
- EPS Growth
- INM N/A
- OZKAP N/A
- EPS
- INM N/A
- OZKAP N/A
- Revenue
- INM $4,942,633.00
- OZKAP N/A
- Revenue This Year
- INM N/A
- OZKAP N/A
- Revenue Next Year
- INM N/A
- OZKAP N/A
- P/E Ratio
- INM N/A
- OZKAP N/A
- Revenue Growth
- INM 7.50
- OZKAP N/A
- 52 Week Low
- INM $1.72
- OZKAP N/A
- 52 Week High
- INM $8.27
- OZKAP N/A
- Technical
- Relative Strength Index (RSI)
- INM 31.68
- OZKAP 43.82
- Support Level
- INM $2.04
- OZKAP $17.25
- Resistance Level
- INM $2.14
- OZKAP $17.57
- Average True Range (ATR)
- INM 0.11
- OZKAP 0.22
- MACD
- INM -0.03
- OZKAP -0.02
- Stochastic Oscillator
- INM 10.87
- OZKAP 21.57
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.
About OZKAP Bank OZK 4.625% Series A Non-Cumulative Perpetual Preferred Stock
Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides a range of banking services which include deposit services such as checking, savings, money market, time deposit, and individual retirement accounts to loan services like real estate, consumer, commercial, and industrial loans. Apart from providing traditional banking products and services it also provides treasury management, trust and wealth management, financial planning, online banking, and other related services.